Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial

OBJECTIVES: To evaluate the efficacy and safety of sacubitril/valsartan according to dose level achieved in the PIONEER-HF trial. BACKGROUND: In patients hospitalized for acute decompensated heart failure (ADHF), in-hospital initiation and continuation of sacubitril/valsartan as compared with enalap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JACC Heart Fail
Autores principales: Berg, David D., Braunwald, Eugene, DeVore, Adam D., Lala, Anuradha, Pinney, Sean P., Duffy, Carol I., Gurmu, Yared, Velazquez, Eric J., Morrow, David A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541586/
https://ncbi.nlm.nih.gov/pubmed/32800511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2020.06.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares